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Sox family transcription factors are well-established regulators of cell fate decisions during development.
Accumulating evidence documents that they play additional roles in adult tissue homeostasis and regener-
ation. Remarkably, forced expression of Sox factors, in combination with other synergistic factors, repro-
grams differentiated cells into somatic or pluripotent stem cells. Dysregulation of Sox factors has been
further implicated in diseases including cancer. Here, we review molecular and functional evidence linking
Sox proteins with stem cell biology, cellular reprogramming, and disease with an emphasis on Sox2.Introduction
Stem cells are characterized by the capacity to continuously
self-renew and the potential to differentiate into one or more
mature cellular lineages (Simons and Clevers, 2011). They serve
to form tissues and organs during mammalian development, and
they maintain ongoing cellular turnover and provide regenerative
capacity in certain adult tissues. One can distinguish between
pluripotent embryonic stem cells (ESCs), which give rise to all
embryonic lineages, and somatic stem cells, which give rise to
one or more specialized lineages within the tissues they reside
in. A stem cell’s decision for self-renewal or differentiation is
intrinsically controlled by the interplay of cell type-specific tran-
scription factors and chromatin regulators. Although several
such molecules have been implicated in stem cell biology over
the last few years, the mechanistic modes of action of these
molecules remain incompletely understood.
Research on the Sox gene family began with the seminal
discovery of the mammalian testis-determining factor, Sry
(Gubbay et al., 1990; Sinclair et al., 1990). Sry carries a character-
istic high-mobility-group (HMG) domain that binds DNA in
a sequence-specific manner. In general, proteins containing
an HMG domain with 50% or higher amino acid similarity to
the HMG domain of Sry are referred to as Sox proteins (Sry-
related HMG box). So far, 20 different Sox genes have been
discovered in mice and humans (Schepers et al., 2002). In addi-
tion, two Sox-like genes have been identified in the unicellular
choanoflagellateMonosiga brevicollis, suggesting that the origin
of Sox proteins predates multicellularity or possibly marks the
transition of unicellular to multicellular organisms (Guth and
Wegner, 2008; King et al., 2008).
Sox proteins that share an HMG domain with more than
80% sequence identity are divided into different groups termed
A to H (Table 1). Individual members within a group share
biochemical properties and thus have overlapping functions
(Wegner, 2010). In contrast, Sox factors from different groups
have acquired distinct biological functions despite recognizingthe same DNA consensus motif. Target gene selectivity by
different Sox factors can be achieved through differential affinity
for particular flanking sequences next to consensus Sox sites,
homo- or heterodimerization among Sox proteins, posttransla-
tional modifications of Sox factors, or interaction with other
cofactors (Wegner, 2010). This molecular versatility may thus
explain why the same Sox factors can play very different molec-
ular and functional roles in distinct biological contexts.
Here, we review the biology of Sox factors that are implicated
in stem cell biology in the context of development, tissue homeo-
stasis, reprogramming, and cancer. We place particular em-
phasis on the well-studied SoxB1 group member Sox2 with
the goal of deriving general molecular and cellular principles by
which Sox factors control stem and progenitor cell fates.
Sox Factors in Preimplantation Development and
Pluripotency
The formation of the trophectoderm (TE) and inner cell mass
(ICM) within the blastocyst is the first lineage specification event
in the mammalian embryo (Rossant and Tam, 2009). The ICM
contains pluripotent founder cells, which give rise to all embry-
onic lineages, and a population of extraembryonic endoderm
(ExEn) cells that contribute to the yolk sac. Similarly, the TE
contains a population of multipotent stem cells that form the
extraembryonic ectoderm and give rise to the placenta. Sox2
is initially present in both the ICM and the TE but is later confined
to the ICM (Avilion et al., 2003). Zygotic deletion of Sox2 results in
early embryonic lethality due to a failure to form the pluripotent
epiblast but leaves the TE unperturbed (Avilion et al., 2003). Inter-
estingly, subsequent studies showed that maternal Sox2 protein
persists in preimplantation embryos, which might have masked
a phenotype in the TE in zygotic Sox2 mutants (Keramari et al.,
2010). Indeed, depletion of bothmaternal and zygotic transcripts
by RNAi causes an early arrest of embryos at the morula stage
and a failure to form TE, suggesting that Sox2 is required for
the segregation of the TE and ICM (Keramari et al., 2010).Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc. 15
Table 1. Sox Factors Implicated in Stem Cell Biology
Group
Sox
Member
Expression
Function
Citations for
Functional RolePreimplantation Embryo Fetus Adult
SoxA Sry Founding member of the Sox family, expression/role in stem cells undefined
SoxB1 Sox1 N/A Neural progenitor cells (NPCs) NPCs Required for specification and
maintenance of undifferentiated
stem cells
Bylund et al. (2003); Graham
et al. (2003); Pevny et al. (1998);
Zhao et al. (2004)
Sox2 Expression/role in ectoderm, endoderm, and mesoderm derivatives, refer to Figure 1 and text for details
Sox3 N/A NPCs NPCs Same as Sox1 Bylund et al. (2003);
Bergsland et al. (2011)
N/A N/A Spermatogonia Genetic deletion leads to loss of
undifferentiated spermatogonia
Raverot et al. (2005)
SoxB2 Sox14, Sox21 Expression/role in stem cells largely undefined*
SoxC Sox4, Sox11, Sox12 Expression/role in stem cells largely undefined*
SoxD Sox5, Sox6, Sox13 Expression/role in stem cells largely undefined*
SoxE Sox8 N/A N/A Muscle satellite
cells
N/A Schmidt et al. (2003)
Sox9 N/A Hair follicle stem cells Hair follicle stem
cells
Deletion leads to loss of specification
of early bulge cells needed to form the
hair follicle and sebaceous gland
Vidal et al. (2005)
Nowak et al. (2008)
N/A Distal tip cells (lung) N/A N/A Rawlins (2011)
N/A NPCs NPCs Required for specification and
maintenance of stem cells (LOF and
GOF studies)
Scott et al. (2010)
N/A Premigratory NCSCs (neural
crest stem cells) and migratory
cranial NCSCs
N/A Cheung and Briscoe (2003)
N/A Retinal progenitor cells (RPCs) N/A Genetic deletion leads to a loss of
stem cell differentiation potential to
Muller glial lineage
Poche´ et al. (2008)
N/A Pancreatic progenitors Exocrine pancreatic
duct cells
Fetal LT marks all pancreatic lineages,
adult LT marks all exocrine lineages.
Genetic deletion leads to loss of
pancreatic progenitors
Seymour et al. (2007);
Furuyama et al. (2011);
Kopp et al. (2011)
N/A N/A Liver duct cells LT labels hepatocytes after injury Furuyama et al. (2011)
N/A N/A Intestinal stem/
progenitor cells
Embryonic and adult LT labels all
intestinal lineages. Genetic deletion
depletes stem cells and Paneth cells
Furuyama et al. (2011);
Sato et al. (2011)
N/A N/A Mammary stem cells
(MaSCs)
Knockdown leads to loss of stem
cell maintenance
Guo et al. (2012)
Sox10 N/A Migratory NCSCs N/A Required for maintenance of stem cells
(LOF andGOF studies in chick embryos)
Kim et al. (2003)
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Cell Stem Cell
ReviewConsistent with its role in preimplantation development, Sox2-
deficient embryos neither support the derivation of ESCs from
the ICM nor the derivation of trophoblast stem cells (TSCs)
from the TE (Avilion et al., 2003). Furthermore, deletion of Sox2
in already established ESCs results in their inappropriate differ-
entiation into trophectoderm-like cells, indicating that Sox2 is
also critical for the maintenance of ESCs (Masui et al., 2007).
Interestingly, Sox2’s effect on self-renewal and differentiation
of ESCs is highly dosage dependent (Kopp et al., 2008), suggest-
ing that its expression needs to be in equilibrium with other
cofactors to maintain pluripotency. Supporting this concept
is the observation that Sox2 acts cooperatively with other
dosage-sensitive transcription factors, such as Oct4 and Nanog,
to maintain the regulatory networks responsible for self-renewal
and to repress differentiation programs in ESCs (Boyer et al.,
2005; Chen et al., 2008; Kim et al., 2008; Orkin andHochedlinger,
2011). Cobinding of these factors at targets associated with self-
renewal facilitates recruitment of the coactivator p300 and con-
sequently transcriptional activation (Chen et al., 2008), whereas
cobinding at developmental target genes causes gene silencing
in concert with the repressive polycomb complex (Boyer et al.,
2006). Notably, a large fraction of target genes bound by these
factors contain composite Oct4/Sox2 consensus binding sites
(Masui et al., 2007; Tomioka et al., 2002), suggesting that Sox2
closely collaborates with Oct4 in order to efficiently bind to
DNA and recruit other factors important for gene activation. In
support of the notion that Oct4 and Sox2 jointly activate many
targets is the finding that overexpression of Oct4 can partially
compensate for the loss of Sox2 (Masui et al., 2007).
Upon specification of the ICM, the SoxF groupmember Sox17
becomes detectable in a rare population of cells destined to form
the ExEn lineage (Kanai-Azuma et al., 2002; Niakan et al., 2010).
Similar to the requirement for Sox2 in ESC and TSC deriva-
tion, Sox17 is essential for the establishment of extraembryonic
endoderm cell lines, termed XEN cells (Kunath et al., 2005; Nia-
kan et al., 2010). At the molecular level, Sox17 has been placed
downstream of the master regulator for primitive endoderm,
Gata6 (Niakan et al., 2010). Accordingly, forced expression of
Sox17 or its related group member Sox7 in ESCs results in a
downregulation of the pluripotency gene expression program
and an upregulation of the primitive endoderm-associated
program, giving rise to endodermal progenitors (Niakan et al.,
2010; Se´guin et al., 2008). Mechanistically, Sox17 seems to
oppose Sox2’s function by repressing pluripotency targets
and activating endoderm targets when ectopically expressed
in ESCs. Chromatin immunoprecipitation (ChIP) experiments
for Sox17 further suggest that this opposition is in part accom-
plished by displacing Nanog from silenced Sox2/Nanog tar-
gets, resulting in their transcriptional activation (Niakan et al.,
2010).
Collectively, these results obtained from in vivo or in vitro
studies document that different Sox factors play important and
often dosage-dependent roles in the establishment of cell lines
of the three main cell lineages of the preimplantation embryo,
the ICM, TE, and ExEn.
Sox2 in Fetal Development
After gastrulation of the embryo, Sox2 expression becomes
largely restricted to the presumptive neuroectoderm, sensoryCell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc. 17
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Reviewplacodes, brachial arches, gut endoderm, and primordial germ
cells (Avilion et al., 2003; Wood and Episkopou, 1999; Yabuta
et al., 2006). Since Sox2 deficiency causes early postimplanta-
tion lethality (Avilion et al., 2003), functional evidence for its
role in the fetus has required analyses of hypomorphic and
conditional mutants in Xenopus, chick, and mouse embryos.
These studies have demonstrated the importance of Sox2 in
lineage specification, morphogenesis, proliferation, and differ-
entiation in a variety of developing tissues of the fetus. In addi-
tion, these data have documented that the function of Sox2 is
highly dosage and context dependent. In the following para-
graphs, we will briefly summarize Sox2’s roles in developing
endodermal, ectodermal, and mesodermal cell lineages.
Sox2 in Ectoderm Development
Sox2 is expressed during the earliest stages of ESC differentia-
tion toward the neural lineage in vitro, supporting a role in neural
commitment. At the molecular level, Sox2 promotes early neuro-
ectodermal fate by directly suppressing key regulators of the
alternative mesendodermal fate such as brachyury (Thomson
et al., 2011; Wang et al., 2012). Sox2 is involved in a similar
cell fate decision in vivo during the differentiation of bipotential
axial stem cells into either paraxial mesoderm or neural plate
(Takemoto et al., 2011). Paraxial mesoderm gives rise to the
vertebral column, dermis, and skeletal muscle, whereas neural
tube develops into the CNS. In the absence of competing
factors, Sox2 drives axial stem cells toward a neural plate fate.
However, in the presence of Tbx6, a regulator of presomitic
mesoderm development, Sox2’s N1 enhancer becomes directly
suppressed and axial stem cells are fated toward paraxial
mesoderm. In agreement, Tbx6 loss or ectopic Sox2 expression
results in the formation of ectopic neural tubes at the expense of
paraxial mesoderm (Takemoto et al., 2011). Together, these
results emphasize the importance of Sox2 in regulating early
neural specification in the embryo and in differentiating ESCs.
The antagonism between Sox2 and Tbx6 in axial stem cells
further exemplifies a general principle bywhich Sox factors regu-
late cell fate decisions during development andwill be discussed
later on.
Sox2 continues to play major roles in the developing CNS and
peripheral nervous system (PNS) by controlling the proliferation
and differentiation of fetal progenitor cells (Pevny and Nicolis,
2010; Wegner and Stolt, 2005). Notably, Sox2 expression over-
laps and functions redundantly with that of the other two
SoxB1 group factors, Sox1 and Sox3 in the CNS (Bylund et al.,
2003; Graham et al., 2003; Wood and Episkopou, 1999) (Table
1). In general, overexpression of any of the SoxB1 factors pro-
motes CNS progenitor cell proliferation, whereas depletion of
these factors induces cell-cycle exit and onset of differentiation
(Bylund et al., 2003; Cavallaro et al., 2008; Ferri et al., 2004; Gra-
ham et al., 2003; Kishi et al., 2000; Miyagi et al., 2008). Likewise,
Sox2 expression is essential for neural progenitor cell prolifera-
tion and differentiation in the retina, in part through its direct acti-
vation of theNotch1 gene (Taranova et al., 2006). Comparison of
Sox2 hypomorphs of various strengths with Sox2 conditional null
mice further suggests that Sox2 function in retinal progenitor
cells (RPCs) is highly dosage dependent. RPCs lacking Sox2
expression lose the competence to proliferate and differentiate,
while reductions in Sox2 levels cause variable microphthalmia.
In addition to neural progenitors of the brain and eye, Sox2 is18 Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc.transiently expressed in the Schwann cell lineage, which is of
neural crest origin and responsible for the myelination of axons
of the PNS. Similar to its role in CNS and retinal progenitors,
Sox2 prevents terminal differentiation of Schwann cell precur-
sors (Le et al., 2005).
Surprisingly, Sox2 expression has also been reported to
be important for the differentiation of subsets of neurons,
indicating that its function is not always confined to the mainte-
nance of progenitors and stem cells. For example, Sox2 hypo-
morphic or knockout mice have reduced GABAergic interneu-
rons in the newborn cortex and adult olfactory bulb (Cavallaro
et al., 2008). Consistently, Sox2 mutant NPC cultures generate
beta-tubulin-positive neuronal-like cells that are poorly arborized
and are negative for markers of mature neurons and GABAergic
neurons (Cavallaro et al., 2008; Ferri et al., 2004). In an inde-
pendent in vitro differentiation paradigm, Sox2 was shown to
promote thematuration of migrating neural crest progenitor cells
into sensory ganglia (Cimadamore et al., 2011). Collectively,
these studies demonstrate that SoxB1 proteins play key roles
in the development of the CNS and the PNS by controlling
both the proliferation and differentiation of various progenitor
cell populations. It will be important to define the mechanisms
by which the same transcription factor regulates progenitor cell
maintenance and differentiation within the same lineage (see
also Mechanisms section/Pioneer factors). Sox2 is expressed
in other developing ectoderm-derived tissues including the inner
ear and dental epithelium, which will not be discussed here
because of space constraints (see Figure 1 for summary) (Dab-
doub et al., 2008; Juuri et al., 2012; Kiernan et al., 2005).
Sox2 in Endoderm Development
Whereas Sox2 counteracts mesoderm specification in vivo and
during ESC differentiation, elegant work by Hogan and col-
leagues showed that it plays multiple additional roles in organ
specification of the foregut endoderm (Figure 1). Sox2 is highly
expressed in the anterior part of the foregut, giving rise to
esophagus and forestomach. However, it is lowly expressed in
the future trachea and posterior stomach, respectively (Que
et al., 2007). A severe decrease in Sox2 levels in hypomorphic
embryos causes a transformation of esophagus into trachea,
resulting in a failure to separate future trachea and esophagus
(tracheoesophageal fistula) (Que et al., 2007). Interestingly,
Sox2 appears to play an independent role in defining the
boundary between the keratinized forestomach/esophagus
and the glandular hindstomach/intestine based on the observa-
tion that Sox2mutant esophagus and forestomach exhibit histo-
logical and molecular signs of glandular stomach and intestine.
Experiments regulating Sox2 dosage have further demonstrated
that Sox2 is required for patterning and morphogenesis of the
embryonic tongue into taste bud sensory cells (Okubo et al.,
2006), branching and differentiation of primary lung bud into
the lung (Gontan et al., 2008; Ishii et al., 1998), and proper differ-
entiation of the tracheal cartilage (Que et al., 2009).
These experiments document an interesting commonality and
difference in how Sox2 controls stem and progenitor cells in
distinct developing tissues. A commonality among stem and
progenitor cells of the retina, foregut-derived tissues, and
pluripotent cells is a sensitivity to changes in Sox2 dose. This
observation is consistent with the presence of cooperative
and/or antagonistic factors whose function depends on finely
Figure 1. Sox2 Expression in Pluripotent,
Fetal, and Adult Progenitor and Stem Cells
Sox2 is expressed throughout development,
initially in pluripotent founder cells of the blasto-
cyst and subsequently in ectodermal, endo-
dermal, and mesodermal derivatives as well as in
primordial germ cells. Sox2 expression is main-
tained in fetal and adult tissues derived from
Sox2+ fetal progenitor cells and marks stem and
progenitor cells and in some cases also differen-
tiated cells.
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Reviewtuned Sox2 levels and will be discussed below. A notable differ-
ence among these tissues is the effect Sox2 deletion has on cell
proliferation.While neural progenitors generally exit the cell cycle
upon Sox2 deletion, trachea, tongue, and esophagus exhibit
altered differentiation programs without changes in cell prolifer-
ation. Thus, Sox2 seems to control tissue formation in cell prolif-
eration-dependent and independent ways that vary from tissue
to tissue. Future studies of Sox2 targets in the respective cell
types might give insights into the molecular mechanisms
responsible for these different outcomes.
Sox2 in Mesoderm Development
During skin development, Sox2 is initially expressed in groups of
mesenchymal cells called dermal condensates, which precede
hair and whisker follicle formation and eventually give rise to
the so-called dermal sheath and dermal papilla (DP) (Driskell
et al., 2009; Rendl et al., 2005). TheDP cyclically provides signals
to the surrounding hair follicle to induce hair growth.While all DPs
express Sox2 until shortly before birth, only a subset of them
continues to be Sox2+ after birth (Driskell et al., 2009). This coin-
cideswith the emergenceof different types ofDP-associated hair
follicles during development. In postnatal mice, Sox2+ DPs are
associated with so-called guard, auchene, and awl follicles,
which form earlier in development, whereas Sox2 DPs are
associated with zigzag follicles that form late in development.
Of note, Sox2+ dermal cells appear to be the cells of origin of
multipotent, self-renewing skin-derived precursors (SKPs) (Fer-
nandes et al., 2004). Both primary Sox2+ dermal cells and clon-
ally derived SKPs induce hair morphogenesis upon transplanta-Cell Stem Celltion into nude mice and differentiate into
multiple dermal cell types in vivo and
neural cells in vitro (Biernaskie et al.,
2009; Driskell et al., 2009). These charac-
teristics identify Sox2+ dermal cells as
putative dermal stem cells. DP cells and
derivative SKPs were originally thought
to originate exclusively from the neu-
ral crest (ectoderm). However, recent
lineage-tracing analyses with a somite-
specific cre (Myf5-cre) driver have refined
this interpretation. Trunk-derived DP cells
and SKPs originate from somites (meso-
derm), while facial-derived DP cells and
SKPs originate from the neural crest
(ectoderm) (Jinno et al., 2010). Evidence
for a functional role for DP-specific Sox2
expression on hair follicle growth has
been provided by the Rendl laboratory(Clavel et al., 2012). DP-specificSox2 ablation leads to derepres-
sion of its target Sostdc1, which normally inhibits Bmp signaling.
A decrease in Bmp signaling from the DP results in a reduction of
hair shaft progenitor cellmigration in the adjacent follicle and thus
impaired hair growth, which resembles that of Sox2-zigzag hairs.
Whether Sox2 also plays a functional role in wound repair and
SKP self-renewal is an interesting question that remains to be
addressed.
Sox2 has also been implicated in the proliferation of osteo-
blast progenitors in vitro and in vivo. Deletion of Sox2 in
cultured osteoblast cell lines leads to a senescence-like pheno-
type, while its overexpression prevents differentiation (Mansu-
khani et al., 2005). Similarly, ablation of Sox2 in the osteoblast
lineage in vivo using a Collagen (2.3 kb)-driven Cre line results
in reduced bone mineral density and bone volume (Basu-Roy
et al., 2010), while transgenic overexpression inhibits mature
osteoblast function (Holmes et al., 2011). Given that osteo-
blasts, like DP cells, can originate from both neural crest and
paraxial mesoderm, it remains to be formally shown that
Sox2 is expressed in osteoblasts derived from both germ
layers. Collectively, these experiments extend Sox2 expression
and function in stem and progenitor cells from ectoderm and
endoderm to that in mesoderm. Another important conclusion
from these observations is that Sox2 can influence progenitor
cell proliferation either directly by preventing cellular differenti-
ation (e.g., in osteoblasts) or indirectly by suppressing prodif-
ferentiation signals produced from adjacent cells (e.g., in DP
cells).12, January 3, 2013 ª2013 Elsevier Inc. 19
Figure 2. Antagonisms between Sox2 and
Other Lineage-Specific Transcription
Factors Determine Cell Fate
During organogenesis, Sox2 influences cell fate
by inhibiting transcription factors that specify
alternative cell lineages. Sox2 is expressed in an
inverse gradient with the respective other tran-
scription factor and thus acts in a dosage-
dependent manner to establish cellular identities
within and boundaries between future tissues.
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Transcriptional Regulators
A common theme emerging from the abovementioned observa-
tions is that Sox2 often determines cell fate by antagonizing
transcription factors of alternative cell lineages (Figure 2). An
example already mentioned in this Review is the antagonism
between Sox2 and Tbx6 during the specification of bipotential
axial stem cells toward either Sox2+ neural tube or Tbx6+ axial
mesoderm (Takemoto et al., 2011). Likewise, Sox2 antagonizes
the transcription factor Nkx2.1 during foregut development;
Sox2 is expressed most anteriorly in the future esophagus and
stomach, whereas Nkx2.1 is expressed ventrally in the future
trachea (Que et al., 2007). Accordingly, embryos deficient for
Nkx2.1 exhibit the reciprocal phenotype to Sox2 mutants dis-
playing ectopic Sox2 expression and a transformation of future
trachea into esophagus (Que et al., 2007). Furthermore, antago-
nism between the stomach-specifying Sox2/Barx1/Sfrp path-
way and the intestinal fate-promoting Wnt/Cdx2 pathway is
responsible for establishing the boundary between the glandular
stomach and the intestine (Zorn and Wells, 2009). Lastly, the
interaction between Sox2 and Mitf/Egr2 regulates the differen-
tiation of Schwann cell progenitors into either myelinating
Schwann cells or melanocytes (Adameyko et al., 2012). Specifi-
cally, Sox2 maintains a Schwann cell progenitor state, whereas
its cross-regulatory interactions with either Mitf or Egr2 consoli-
date mature Schwann cell or melanocyte fates, respectively
(Adameyko et al., 2012). The suppression of Mitf expression by
Sox2may be direct since Sox2 protein was detected at the prox-
imal Mitf-m promoter in ESCs and melanoma cell lines (Ada-
meyko et al., 2012). Whether mutual repression between Sox2
and Nkx2.1 or Sox2 and Cdx2 also involves direct binding to
the respective regulatory regions remains to be determined.
Development of a Sox2 overexpression mouse model showed
that Sox2 activates Sox21, which in turn binds to and represses
Cdx2 in ESCs and neural progenitors, thus arguing for an indirect20 Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc.mechanism in this particular context
(Kuzmichev et al., 2012). Together, these
observations underscore a general prin-
ciple of how Sox2 drives cell fate deci-
sions during development, namely by
directly or indirectly inhibiting regulators
of alternative cell fates.
It is important to recognize, however,
that the antagonisms between Sox2 and
other transcription factors are highly cell
type and developmental stage specific.
In fact, transcription factor pairs that are
antagonistic in one cell type or develop-mental stage may cooperate in other cellular or developmental
settings. A case in point is the Sox2/Pax6 pair. Ablation of
Sox2 in multipotent optic cup progenitors biases them toward
a nonneurogenic ciliary body epithelium fate (Matsushima
et al., 2011). This phenotype is rescued in a Pax6 heterozygous
(haploinsufficient) background (Matsushima et al., 2011), indi-
cating that Sox2 specifies a neurogenic fate, whereas Pax6
instructs a nonneurogenic fate. In contrast to this antagonistic
relationship during development of the optic cup, Sox2 and
Pax6 cooperate during lens development by forming a complex
on lens-specific enhancer elements such as that of the delta
crystalline gene (Kamachi et al., 2001). In support of the cooper-
ative role of Sox2 and Pax6 in lens specification, combined
expression of both factors is sufficient to differentiate embryonic
ectoderm into lens ectoderm.
Sox2 in Tissue Homeostasis and Regeneration
Accumulating data indicate that tissues that require Sox2 during
development continue to express this factor in some adult stem
and progenitor cells derived from that tissue (Figure 1). Below,
we will review the expression patterns and, where available,
functional data linking Sox2 with adult stem and progenitor cells.
Using Sox2-GFP knockin mice, Pevny and coworkers first
demonstrated that Sox2 is not only expressed in fetal neural
progenitors but also in proliferating cells in the adult CNS, specif-
ically in neurogenic regions, such as the subventricular zone of
the lateral ventricle and the subgranular zone of the hippo-
campus as well as the ependyma of the adult central canal (Ellis
et al., 2004). Isolated Sox2+ adult NPCs can be propagated in
culture whilemaintaining their ability to differentiate into neurons,
astrocytes, and oligodendrocytes, thus documenting their self-
renewal and multipotency in vitro (Ellis et al., 2004). The self-
renewal and differentiation capacities of Sox2+ adult NPCs
were verified in vivo by Fred Gage’s group using lenti- and retro-
viral-mediated fate mapping approaches (Suh et al., 2007).
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down experiments in vitro (Cavallaro et al., 2008) and conditional
deletion of Sox2 specifically in the brain (Favaro et al., 2009; Ferri
et al., 2004). These experiments revealed that Sox2 depletion
in cultured NPCs attenuates their potential to form neurons,
whereas its absence in vivo causes a rapid loss of GFAP- and
Nestin-expressing precursor cells and a decline in cell pro-
liferation in the dentate gyrus, indicating that Sox2 marks and
maintains NPCs and hence neurogenesis in the adult mouse
hippocampus. Together, these studies demonstrate that Sox2
regulates both developmental and adult stem cell populations
in the brain.
Sox2marks stem and progenitor cell populations in other adult
tissues that depend on Sox2 expression during development.
For example, Sox2+ cells have been detected in progenitors of
the adult retina (Taranova et al., 2006), trachea (Que et al.,
2009), tongue epithelium (Okubo et al., 2009), and dermal papilla
of the hair follicle (Biernaskie et al., 2009; Driskell et al., 2009), as
well as in putative progenitors of the pituitary gland (Fauquier
et al., 2008). More recently, lineage-tracing experiments from
our laboratory and others have demonstrated that immature
Sox2+ cells in the adult testes, forestomach, glandular stomach,
trachea, anus, cervix, esophagus, lens, and dental epithelium
give rise to all mature cell types within these tissues (Arnold
et al., 2011; Juuri et al., 2012). Conditional Sox2 deletion in all
tracheal cells has further shown that postnatal expression of
Sox2 is required to sustain tracheal homeostasis by controlling
the number of proliferating epithelial cells as well as the propor-
tion of basal, ciliated, and Clara cells. The effect of Sox2 loss on
tracheal cell proliferation thus represents an interesting differ-
ence compared with Sox2 loss in the embryonic trachea, which
does not perturb proliferation (Que et al., 2009). Deletion of Sox2
specifically in bronchiolar Clara cells, which serve as facultative
stem cells, also causes reduced cell proliferation and a gradual
loss of differentiation markers for Clara, ciliated, and mucous
cells (Tompkins et al., 2009). This loss indicates that Sox2 is
required for the self-renewal of Clara cells and their differentia-
tion into ciliated and mucous cells. From a molecular viewpoint,
compromised bronchiolar cell proliferation might result from
a derepression of the Sox2 target gene Smad3, thus possibly
activating the antiproliferative Tgf-b pathway (Tompkins et al.,
2009). An important question that remains to be determined is
whether Sox2 expression is required for homeostasis in other
Sox2+ adult tissues besides the airways and the brain.
In addition tomaintaining tissue homeostasis, Sox2 is involved
in tissue repair. For instance, chemically induced damage of the
tracheal epithelium in mice is typically repaired within 7–10 days
due to the activity of basal stem cells (Que et al., 2009). Sox2-
deficient trachea, however, fail to undergo efficient tissue repair
with severe reductions in the number of basal, ciliated, and Clara
cells. Peripheral nerve regeneration is another example for
Sox2’s role in tissue repair. Upon injury, mature adult Schwann
cells re-express Sox2, shed their myelin sheaths and dedifferen-
tiate to a progenitor cell-like state (Parrinello et al., 2010). Sox2
seems to play a direct role in this process by organizing Schwann
cell clustering, a key event during nerve regeneration, through
relocating N-Cadherin molecules. This process then enables
Schwann cells to formmulticellular cords to guide axon regrowth
across the site of injury. It should be interesting to determinewhether Sox2 is reactivated and plays functional roles in other
tissues experiencing cellular damage by promoting dedifferenti-
ation into, or expansion of, resident progenitors.
Sox2 and Disease
Sox2 Deficiency in Developmental Disorders
SOX2 mutations have been identified in a number of develop-
mental diseases and cancer. For example, humans carrying a
heterozygous mutation for SOX2 develop anophthalmia-esoph-
ageal-genital (AEG) syndrome. These patients have abnor-
malities in ectodermal and endodermal tissues including micro-
phthalmia (small eyes), trachea-esophageal fistula, hearing loss,
and brain abnormalities (Kelberman et al., 2006; Williamson
et al., 2006). The heterozygous manifestation of disease in
patients is consistent with the dose-dependent functions of
Sox2 seen in mice. Surprisingly, however, heterozygous mutant
mice are comparatively normal although they exhibit reduced
pituitary size and hormone production as well as testicular
atrophy and infertility with age, possibly from dose-dependent
effects on pituitary and germ cell progenitors (Kelberman et al.,
2006).
Sox2 Dysregulation in Cancer
Accumulating evidence suggests that SOX2 acts as an onco-
gene in some epithelial cancers. The SOX2 locus is amplified
in human squamous cell carcinomas of the lung (23%) and
esophagus (15%) as well as in 27% of human small cell lung
cancers analyzed (Bass et al., 2009; Rudin et al., 2012). Consis-
tently, overexpression of Sox2 in the lungs of mice induces rapid
hyperproliferation (Tompkins et al., 2011) and, in some cases,
adenocarcinomas (Lu et al., 2010), although SOX2 amplifica-
tions have not yet been described in human lung adenocarci-
nomas. While the molecular function that Sox2 plays in tumori-
genesis remains to be determined, recent evidence points
toward proproliferative, prosurvial, and/or antidifferentiation
roles. For instance, knockdown of SOX2 in human cell lines,
derived from squamous cell caricinomas and small cell lung
cancer, compromises growth (Bass et al., 2009; Rudin et al.,
2012). Moreover, genetic reduction of Sox2 levels by half in an
animal model of pituitary cancer significantly reduces tumor
formation (Li et al., 2012a). Lastly, Sox2 was shown to be critical
for the proliferation and differentiation of human osteosarcoma
cell lines in vitro and in an in vivo transplantation model by antag-
onizing WNT signaling. SOX2 expression has also been sug-
gested to contribute to cellular invasion in tumors of neural
and neural crest origin such as glioma (Ikushima et al., 2009),
melanoma (Laga et al., 2010), and Merkel cell carcinoma (Laga
et al., 2010), in which it is overexpressed. Thus, analogous
to its multiple roles in development and differentiation, Sox2
appears to function at various levels of carcinogenesis to pro-
mote tumor growth.
An important question is whether Sox2 is already expressed in
the cell of origin for these tumors or whether it is activated ectop-
ically. While it is plausible that tumors forming within Sox2+
tissues originate from a Sox2+ cell type (e.g., lungs, esophagus,
neural cells, and Merkel cells), unequivocal (genetic lineage
tracing) evidence for this conclusion is lacking. Interestingly,
two reports detected ectopic Sox2 expression in rare tumor
stem cell-like populations isolated from genetically induced
mouse models of squamous cell carcinoma of the skin (BeckCell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc. 21
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epidermis (ectoderm) has a similar structure as the Sox2+ squa-
mous epithelia of the gastrointestinal tract (endoderm), Sox2 is
not normally expressed in skin keratinocytes. It remains to be
tested whether ectopic Sox2 expression has any functional
consequences on these tumors. It is further interesting to note
in this context that the ectopic expression of the reprogramming
gene Oct4 in mice results in rapid but reversible tumor formation
in several Sox2-expressing squamous epithelia by expanding
adult progenitors and preventing their differentiation (Hochedlin-
ger et al., 2005). It is therefore conceivable that Oct4 and Sox2
cooperate in these tissues, like in pluripotent cells, to induce
tissue hyperplasia.
Involvement of Other Sox Factors in Stem Cell Biology
Like Sox2, the SoxE group member Sox9 is expressed in several
endoderm-derived and ectoderm-derived tissues. For example,
Sox9 marks stem and progenitor cells in the adult intestine,
liver, and exocrine pancreas that produce a continuous supply
of enterocytes, hepatocytes, and acinar cells, respectively,
under both homeostatic and certain injury conditions (Furuyama
et al., 2011). In addition to these endodermal tissues, Sox9 func-
tions to maintain stem cells in ectodermal tissue stem cells
including the hair follicles of the adult skin (Nowak et al., 2008),
multipotent mouse retinal progenitor cells (Poche´ et al., 2008),
NPCs (Scott et al., 2010), neural crest stem cells (Cheung and
Briscoe, 2003), and mammary stem cells (Guo et al., 2012).
Furthermore, Sox9 is upregulated in a number of neural tumors
and basal cell carcinomas (Kordes and Hagel, 2006; Miller
et al., 2006; Nowak et al., 2008), and expression of Sox9
promotes the tumorigenic and metastasis-seeding abilities of
human breast cancer cells in a transplant model (Guo et al.,
2012), raising the interesting possibility that Sox9 confers stem
cell-like properties upon tumor cells.
Other Sox factors have been implicated in stem cell mainte-
nance, which will not be covered in detail in this Review (Table
1). Briefly, expression of Sox10, which like Sox9 is a member
of the SoxE group, ensures stem cell survival, maintains multipo-
tency and suppresses neuronal differentiation in neural crest
stem cells (Kim et al., 2003). The SoxF group member Sox17 is
required for themaintenance of fetal and neonatal hematopoietic
stem cells (HSCs) but is dispensable in adult hematopoiesis (Kim
et al., 2007). The SoxE group member Sox8 and the SoxG group
member Sox15 mark muscle satellite cells, and their individual
overexpression in amyoblast cell line preventsMyoD expression
and differentiation into myotubes (Meeson et al., 2007; Schmidt
et al., 2003). Individual knockout mice for Sox8 and Sox15 do not
have an overt phenotype, suggesting redundancy. However,
Sox15 mutant mice exhibit defects in muscle regeneration, indi-
cating a requirement for Sox15 after injury (Meeson et al., 2007).
Finally, the SoxB1 group member Sox3 marks undifferentiated
spermatogonia, and its depletion leads to loss of spermatogen-
esis and nearly agametic male mice (Raverot et al., 2005).
A few general conclusions can be drawn from these and
other studies examining different Sox genes in stem cell biology.
First, most Sox factors are expressed in multiple types of
stem and progenitor cell types. Second, many Sox factors act
redundantly in the maintenance of stem cells (e.g., Sox1, Sox2,
Sox3, and Sox9 in NPCs), which may explain why certain Sox22 Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc.gene knockouts do not exhibit obvious phenotypes due to
compensation by other Sox factors. Third, different Sox factors
may be expressed at subsequent stages of differentiation within
a cell lineage (e.g., Sox2/Sox3 and Sox11 during NPC differenti-
ation into neurons or Sox9 and Sox10 during neural crest stem
cell differentiation and migration) (Bergsland et al., 2011; Guth
and Wegner, 2008). Lastly, Sox factors may be expressed in
complementary patterns within a developing or adult tissue
(e.g., Sox9 and Sox2 in multipotent distal tip cells and proximal
epithelial cells in the developing lung, (Rawlins, 2011) or in bulge
stem cells and DP cells of the hair follicle, respectively (Nowak
et al., 2008; Driskell et al., 2009)). The broad expression patterns
and the partial redundancy ofmany Sox factors are thought to be
the consequence of subfunctionalization and neofunctionaliza-
tion of Sox genes resulting from an expansion of Sox genes
during vertebrate evolution (Guth and Wegner, 2008).
Sox Factors in Cellular Reprogramming
Given that Sox factors play critical roles in establishing andmain-
taining cell types during development and in the adult, it is
conceivable that their ectopic expression in heterologous cell
types is sufficient to change cell fates. Indeed, Sox2 is one of
the key reprogramming factors for the derivation of induced
pluripotent stem cells (iPSCs) from somatic cells. Sox2 is
required toward the end of reprogramming (Chen et al., 2011),
presumably by activating its own transcription as well as
hundreds of pluripotency-associated targets to stabilize the
pluripotent state. In fact, a recent study by Jaenisch and col-
leagues suggested that activation of the endogenous Sox2 locus
during cellular reprogramming initiates a cascade of transcrip-
tional events that takes place exclusively in cells destined to
form iPSCs (Buganim et al., 2012). Notably, as a reprogramming
factor, Sox2 can be replaced by the most closely related Sox
family members, Sox1 and Sox3, but not by more distant
members Sox7, Sox15, Sox17, or Sox18 (Nakagawa et al.,
2008). The finding that certain Sox factors cannot replace Sox2
despite similar DNA binding characteristics might result from
the differential abilities of Sox factors to interact with Oct4 to
activate common target genes. In support of this notion single
amino acid substitutions within the Oct4 domain that normally
interact with Sox2 in ESCs can abrogate its ability to generate
iPSCs (Jauch et al., 2011). Conversely, introducing Sox17-
compatible amino acid changes into this Oct4 domain generates
a variant that no longer recognizes Sox2 and instead endows
Sox17 with the potential to induce pluripotency in combination
with Oct4, Klf4, and c-Myc (Jauch et al., 2011). This experiment
corroborates the notion that the binding partners of Sox2 often
confer target gene specificity, resulting in the activation of
different gene expression programs in cells that express the
same Sox factors.
Surprisingly, Sox2 is dispensable for pluripotency gene activa-
tion in somatic cells after cell fusion with ESCs. This nonessential
role contrasts with a requirement for Oct4 during cell fusion-
mediated reprogramming and might suggest that Oct4 can
compensate for the loss of Sox2 in this context, similar to what
was seen in self-renewing ESCs (Masui et al., 2007). Alterna-
tively, Sox15, which is also expressed in ESCs (Maruyama
et al., 2005), might replace Sox2 exclusively during fusion-
induced reprogramming.
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Figure 3. Sox Factors as Inducers of Cellular
Reprogramming
Examples of Sox factors whose enforced expres-
sion in other cell types induces dedifferentiation.
(A) Ectopic expression of Sox2 in combination with
Klf4, Oct4, and c-Myc endows somatic cells with
pluripotency, giving rise to induced pluripotent
stem cells (iPSCs).
(B) Sox2 expression alone or together with other
factors reprograms fibroblasts into induced neural
stem cells (iNSCs).
(C) Sox9 expression in combination with Slug
expression, converts differentiated luminal cells
into mammary stem cells capable of generating
an entire mammary ductal tree when transplanted
into a mammary fat pad.
(D) Sox17 expression in adult hematopoietic stem
and progenitor cells induces a fetal-like hemato-
poietic stem cell state. These cells have increased
self-renewal potential and express HSC markers.
However, long-term Sox17 expression in the adult
leads to leukemogenesis.
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transcription factors has been reported to directly reprogram
fibroblasts into neural stem cells (Han et al., 2012; Ring et al.,
2012; Thier et al., 2012), suggesting that Sox2 can induce
different cell fates depending on the presence of cofactors and
environmental cues. This notion is in agreement with an earlier
finding by Kondo and Raff, who discovered that exposure of
rat oligodendrocyte progenitors to PDGF and bFGF induced
their reversion into self-renewing multipotent NPC-like cells
capable of giving rise to astrocytes, oligodendriocytes, and neu-
rons (Kondo and Raff, 2000, 2004). Interestingly, the authors
showed that this growth factor-mediated reversion depends on
the reactivation of the Sox2 locus through a mechanism that
involves direct recruitment of the chromatin remodeling factor
Brahma and the tumor suppressor Brca1 to its promoter region
(Kondo and Raff, 2004).
The ability to induce new cell states from heterologous cell
types has recently been demonstrated for other Sox family
members including Sox9 and Sox17. Specifically, coexpression
of Sox9 and Slug in differentiated luminal cells produces induced
multipotent cells which have long-term mammary gland recon-
stituting potential in transplantation assays (Guo et al., 2012).
Similarly, forced expression of the fetal HSC transcription factor
Sox17 in adult committed progenitors endows them with fetal
HSC characteristics including an enhanced self-renewal poten-
tial, long-term multilineage reconstitution ability, and biased
erythroid and myeloid differentiation over lymphoid differentia-
tion, although prolonged overexpression causes leukemia (He
et al., 2011). Together, these findings underscore the powerful
effects Sox factors have in endowing differentiated cells with
immature stem cell-like properties (summarized in Figure 3).
Mechanismsbywhich Sox2Controls Cell FateDecisions
Sox2 expression, like that of many other Sox factors, is modu-
lated by extracellular signals and intracellular cofactors. Here,
we review examples of how Sox2 expression can be positively
or negatively regulated by different extracellular cues in differenttissues and discuss intracellular mechanisms by which Sox2
expression is controlled in pluripotent and adult stem cells
(Figure 4).
Extracellular Regulators of Sox2 Expression
Sox2 expression is positively and negatively influenced by dif-
ferent extracellular signals in vivo and in vitro. For instance, Fgf
signaling from the surrounding ventral mesenchyme negatively
regulates Sox2 expression during embryonic foregut patterning,
resulting in a separation of esophagus and trachea (Que et al.,
2007). In the developing taste buds, Wnt signaling induces
Sox2 expression in endodermal progenitors, causing their differ-
entiation into taste bud cells at the expense of keratinocytes
(Okubo et al., 2006). In calvarial osteoblast progenitors, how-
ever, Sox2 is positively regulated by Fgf signaling. Upregulation
ofSox2, in turn, inhibitsWnt signaling bymeans of physical asso-
ciation of Sox2 with beta-catenin (Mansukhani et al., 2005).
In cultured pluripotent ESCs, Sox2 targets are co-occupied
by Smad1 and Smad3 proteins, the downstream effectors of
Tgf-b signaling that are essential for self-renewal (Chen et al.,
2008; Mullen et al., 2011). Notably, one of the genes targeted
byOct4, Sox2, and Smad3 is the Tgf-b inhibitor Lefty1, indicating
that tight regulation of this pathway is necessary to maintain
pluripotency. Similar to Tgf-b signaling in ESCs, Egf and Shh
signaling stimulate Sox2 expression in NPCs (Favaro et al.,
2009). Once activated, Sox2 binds to the Egfr and Shh genes
among many other targets, thus engaging in positive feedback
loops that are important for themaintenance of stem cells (Enge-
len et al., 2011; Hu et al., 2010). In agreement with this molecular
link, Sox2-deficient NPCs fail to produce sufficient Shh, leading
to loss of NPC cultures and dentate gyrus hypoplasia, respec-
tively (Favaro et al., 2009). Remarkably, these phenotypes can
be partially restored in vitro and in vivo by supplying recombinant
Shh or an Shh agonist (Favaro et al., 2009). A similar connection
has been observed between Shh and Sox9 in NPCs (Scott et al.,
2010). In contrast to Shh and Egf signaling, which promotesSox2
expression, thyroid hormone signaling induces differentiation
of neural progenitors into neuroblasts by suppressing Sox2Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc. 23
BA Figure 4. Mechanisms by which Sox2
Controls Self-Renewal and Differentiation in
Pluripotent and Multipotent Stem Cells
(A) Sox2 activates self-renewal genes and re-
presses differentiation genes in a cell type-specific
manner by (1) interpreting tissue-specific signals
and (2) interacting with other cell type-specific
cofactors. For example, in ESCs, Sox2 occupies
many targets containing Oct4-Sox2 consensus
sequences and partners with downstream effec-
tors of ESC-specific signaling pathways including
Stat3 (LIF pathway). In NPCs, Sox2 occupies target
genes that also contain binding sites for the brain-
specific factors Brn2 and Chd7, thus activating
different sets of genes. In addition, Sox2 activates
its own transcription and regulates components of
the signaling pathways that control self-renewal,
thereby promoting maintenance of the undifferen-
tiated state.
(B) In addition to activating self-renewal genes and
suppressing lineage-specific genes, Sox2 acts as
a pioneer factor to prime stem cells for subsequent
gene activation. Sox2 occupies silent NPC genes
in ESCs, which carry bivalent domains poised for
gene activation. Upon differentiation into NPCs,
Sox2 and Sox3 cooperate to activate self-renewal
genes while keeping neuronal differentiation genes
in a silent but bivalent state. When NPCs undergo
terminal differentiation, Sox2 and Sox3 disengage
from neuronal-specific enhancers and are re-
placed by Sox11.
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receptor-alpha1 binds to a negative thyroid hormone response
element within theSox2 enhancer, resulting inSox2 repression in
a hormone-dependent fashion. Finally, Ephrin signaling causes
Sox2 stabilization during Schwann cell regeneration, leading to
N-Cadherin remodeling and subsequent Schwann cell clustering
(Parrinello et al., 2010). In summary, these and several other
examples (Domyan et al., 2011; Takemoto et al., 2006) demon-
strate that major signaling pathways can positively or negatively
control Sox2 expression levels during embryonic development,
stem cell homeostasis, and tissue regeneration in a context-
dependent manner. Furthermore, Sox2 itself often modulates
these signals by directly activating or repressing key regulators
of these pathways.
Intracellular Modulators of Sox2 Expression in
Pluripotent Stem Cells
Once Sox2 is activated by extracellular signals, intracellular
cofactors ensure that the proper set of target genes is activated
in a cell type-specific fashion. One way to achieve this is to
collaborate with other cell type-specific transcription factors.
As discussed earlier, Sox2 physically associates with and co-
occupies targets with other key pluripotency factors including
Oct4 and Nanog in ESCs, thus contributing to target gene spec-
ificity. Of note, the combination and complexity of these plu-
ripotency transcription factors at individual targets determines
whether they will be activated or repressed. That is, targets
bound by one or few transcription factors tend to be repressed,24 Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc.whereas targets occupied by multiple
factors tend to be expressed in ESCs
(Kim et al., 2008; Sridharan et al., 2009).
To ensure maintenance of the undifferen-
tiated state of ESCs, Sox2 as well as otherpluripotency factors engage in autoregulatory loops to boost
their own expression (Boyer et al., 2005).
The observation that ectopic expression of Oct4 and Sox2
alone are insufficient to activate the well-known target gene
Nanog in a cell-free system (Fong et al., 2011) motivated efforts
to identify additional cofactors. Tjian and colleagues employed
an elegant biochemical approach to purify the ‘‘stem cell coacti-
vation complex’’ (SCC) that collaborates with Oct4 and Sox2 to
transcriptionally activate theNanog promoter. SCC components
also occupy hundreds of other Oct4/Sox2 targets in ESCs as
determined by ChIP-seq analysis (Fong et al., 2011). The SCC
complex contains the trimeric XPC-nucleotide excision repair
complex and is thought to act as a molecular link that couples
stem cell-specific gene expression programs with genome sur-
veillance and stability in ESCs. Interestingly, the tumor sup-
pressor protein p53 has recently been implicated in a similar
role in ESCs. However, unlike the SCC complex, p53 binds to
the distal enhancers of ESC-specific genes including Sox2,
causing their repression upon DNA damage (Li et al., 2012b).
In ESCs, Sox2 additionally requires binding of chromatin
modifiers to induce expression of pluripotency-associated tar-
gets and repression of differentiation-associated targets. For
example, Sox2, Oct4, and Nanog cooperate with WD repeat
domain 5 (Wdr5), an effector of activating H3K4 methylation, to
maintain robust expression of self-renewal genes in ESCs (Ang
et al., 2011). Active Sox2 targets are also cobound by compo-
nents of the cohesion and mediator complex responsible for
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gene expression (Kagey et al., 2010). Recent evidence suggests
that Sox2 might even interact with ESC-specific long noncoding
RNAs (lncRNAs) (Ng et al., 2012) to silence differentiation-asso-
ciated genes in self-renewing ESCs.
During ESC differentiation, ESC-associated genes need to
be rapidly downregulated, which is again achieved by multiple
mechanisms. For example, the H3K4/K9 demethylase Lsd1
and HDACs1/2 silence active Oct4/Sox2-occupied enhancers
in ESCs (Whyte et al., 2012). Recent evidence further documents
an unanticipated role for cell-cycle inhibitors in transcrip-
tional suppression of stem cell genes. The cell-cycle-dependent
kinase inhibitor p27, which is rapidly activated as cells differen-
tiate and thus exit the cell cycle, directly binds to and inhibits
Sox2’s SRR2 enhancer (Li et al., 2012a). In parallel with these
transcriptional and epigenetic mechanisms, negative feedback
loops kick in during differentiation that shut down the pluripo-
tency program at the posttranscriptional level. This is exempli-
fied by RNA miR-145, which is normally repressed by OCT4 in
ESCs, and becomes activated to target OCT4, SOX2, and
KLF4 RNAs for degradation when ESCs differentiate (Xu et al.,
2009a). Thus, Sox2 interacts at the genic, transcript, and protein
levels with other core pluripotency factors, DNA repair com-
plexes, cell-cycle regulators, miRNAs, activating, and repressive
chromatin regulators to control specific gene expression pro-
grams that balance the decision between self-renewal and dif-
ferentiation in pluripotent cells.
Intracellular Modulators of Sox2 Expression in Adult
Stem Cells
Similar to ESCs, Sox2 induces the expression of self-renewal
pathways and inhibits the expression of differentiation genes in
NPCs. Because Oct4 and other pluripotency-associated genes
are silenced in NPCs, Sox2 partners with different transcription
factors to activate alternative targets. In early neural progenitors,
Sox2 has been shown to interact with the brain-specific POU
factor Brn2 to activate the NPC-associated Nestin gene (Tanaka
et al., 2004). More recently, the chromatin remodeling ATPase
Chd7, which has been associated with CHARGE syndrome,
was shown to physically interact and co-occupy targets with
Sox2 in NPCs (Engelen et al., 2011). Sox2 and Chd7 coregulate
a set of target genes of the Notch and Shh signaling pathways
important for stem cell self-renewal. The nuclear receptor tailess
(TLX) has been identified as another key target of Sox2 in NPCs.
TLX functions as a transcriptional repressor that is important for
NPC maintenance and neurogenesis in adult mice. Sox2 physi-
cally interacts with TLX and forms complexes on DNA, possibly
to suppress differentiation genes (Shimozaki et al., 2012).
Sox2 expression itself is maintained in NPCs by direct tran-
scriptional activation through Ars2, a zinc finger protein typically
involved in miRNA biogenesis (Andreu-Agullo et al., 2011). Chro-
matin immunoprecipiation experiments have shown that Ars2, in
a miRNA pathway-independent manner, binds to the promoter
region of Sox2 and activates its expression. Ars2 deletion leads
to a loss of NPC self-renewal and multipotency both in vitro and
in vivo. Importantly, this defect can be rescued by Sox2 overex-
pression (Andreu-Agullo et al., 2011). Similarly, the transcription
factor myeloid Elf-1-like factor (MEF) binds to the Sox2 locus and
stimulates its expression in the context of neurospheres and
glioma cells (Bazzoli et al., 2012). Forced Sox2 expression alsorescues the inability of MEF/ cells to form neurospheres. In
analogy to p27’s inhibition of Sox2 expression during ESC differ-
entiation, the cell-cycle-dependent kinase inhibitor p21 was
shown to suppress Sox2 expression during NPC differentiation
(Marque´s-Torrejo´n et al., 2013).
Posttranslational modifications, such as acetylation (Baltus
et al., 2009; Sikorska et al., 2008), sumoylation (Tsuruzoe et al.,
2006), phosphorylation (Jeong et al., 2010), and arginine methyl-
ation (Zhao et al., 2011), have also been described to influence
the transcriptional activity of Sox2 in ESCs or NPCs. In the case
of Sox2, these modifications cause either transcriptional activa-
tion (phosphorylation, methylation) or repression (sumoylation,
acetylation) by controlling Sox2’s stability, nuclear-cytoplasmic
localization, or transactivation potential. Collectively, these re-
sults demonstrate that Sox2+ adult stem cells utilize some of
the same, as well as different, mechanisms as ESCs to control
the balance between self-renewal and differentiation. It is worth
mentioning that Sox2 has been shown to collaborate with addi-
tional transcription factors in the development of other tissues.
We refer to an excellent review exploring the various partners of
Sox proteins for greater detail (Kondoh and Kamachi, 2010).
Sox Proteins as Pioneer Factors
Pioneer factors are transcription factors that occupy silenced
target genes in progenitor cells and keep them in a poised
state for activation at subsequent stages of differentiation (Zaret
and Carroll, 2011). A classical example is the transcription fac-
tor FoxD3, essential for the maintenance of ESC self-renewal
(Hanna et al., 2002). FoxD3 occupies the enhancer of the silent
liver-specific Alb1 gene in ESCs, thereby keeping it poised for
activation upon differentiation into liver cells, when FoxA1
replaces FoxD3 to activate transcription (Xu et al., 2009b).
Recent evidence exploring the genome-wide targets of different
Sox factors during neural differentiation from ESCs supports
the notion that Sox factors may also function as pioneer factors
and thus contribute to differentiated cell fates (Bergsland et al.,
2011). In ESCs, Sox2 binds to ESC-specific enhancers, which
are active and carry H3K4me3 marks, as well as to neural
enhancers, which are silent and carry bivalent H3K4me3/
H3K27me3 marks. Upon differentiation into NPCs, Sox2 collab-
orates with Sox3 to relocate from pluripotent to neural-specific
gene enhancers. These enhancers either are active in NPCs
and hence carry the H3K4me3 mark or are inactive but poised
and hence carry bivalent marks. After neuronal differentiation,
both types of enhancers exchange their SoxB1 factors for
SoxC factors, including Sox11. At the same time, previously
active NPC enhancers acquire the repressive H3K27me3 mark,
whereas the poised bivalent enhancers convert to a monvalent
H3K4-enriched chromatin signature, resulting in gene activation.
Sox2 might also act as a pioneer factor during hematopoeisis.
In ESCs, Sox2 and FoxD3 bind together to the enhancers of the
repressed bivalent lambda5-VpreB1 and Pax5 genes important
in pro/preB cells (Liber et al., 2010). Specifically, Sox2 has
been suggested to mediate deposition of a tightly localized
peak of H3K4 di and trimethylation at these enhancers whereas
Foxd3 suppresses intergenic transcription. Sox2 is subsequently
replacedby theSoxCgroupmemberSox4andFoxD3by another
Forkhead transcription factor in hemangioblasts, which are early
progenitors for the hematopoietic and endothelial lineages,
leading to robust gene activation during B cell differentiation.Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc. 25
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whether Sox2 along with the transcription factors Oct4, Klf4,
and c-Myc may also function as pioneer factors during iPSC
generation. An examination of binding patterns of the four
factors 48 hr after their induction in fibroblasts showed that
Sox2, Oct4, Klf4, and c-Myc mostly bind to enhancers of early
reprogramming genes, which are not yet activated (Soufi et al.,
2012). While Sox2, Oct4, and Klf4 expression alone allow access
of these targets, c-Myc expression alone does not. Thus, Sox2,
Oct4, and Klf4 indeed seem to act as pioneer factors for c-Myc
early in reprogramming. In addition, c-Myc expression enhances
binding of Oct4, Klf4, and Sox2 to their targets, thus facilitating
efficient chromatin engagement. Together, these three exam-
ples expand the role of Sox2 from a transcriptional activator
to a pioneer factor that poises silenced genes for expression
during normal development and cellular reprogramming.
Concluding Remarks
The molecular and functional analyses of the Sox family of tran-
scription factors over the past two decades have documented
their important roles in various aspects of stem cell biology:
Biochemical dissection of protein interaction partners and DNA
targets using genome-wide approaches has provided a molec-
ular explanation for the previously observed versatility of indi-
vidual Sox factors in regulating proliferation and differentiation
of progenitor and stem cells in different tissues and at different
stages of development. Sox factors respond to different extra-
cellular signals and interact with a host of intracellular cofactors,
such as cell type-specific transcription factors and chromatin
regulators, to control different sets of genes in distinct cell types.
In addition, Sox factors compete with transcription factors of
alternative lineages to drive different cell fates during develop-
ment. At the molecular level, this is often accomplished by
directly activating genes that promote their own lineage and re-
pressing genes of alternative lineages. Interestingly, the compar-
ison of genomic binding sites of different Sox proteins along
a neural differentiation paradigm demonstrated that Sox factors
do not simply serve to activate self-renewal genes and repress
differentiation genes but also function as pioneer factors to poise
genes for activation by a related Sox factor once differentiation
ensues. It should be informative to determine whether this prin-
ciple also applies to Sox factors in other cellular lineages (e.g.,
Sox17 in hematopoietic cells or Sox9 in hair follicle cells).
Most insights into the biology of Sox factors have come from
developmental studies. The finding that Sox factors are also ex-
pressed in numerous adult stem and progenitor cell populations
raises interesting questions about the molecular and functional
roles they play in tissue homeostasis and regeneration com-
pared with their functions during development. The availability
of appropriate mouse models and the ability to maintain rare
stem cell populations in culture, combined with genome-wide
technologies, should now enable researchers to address this
fundamental question at the mechanistic level.
Reprogramming experiments have underscored the power of
Sox factors in switching cell fates. However, the underlying
mechanisms are still poorly understood. It might be possible to
predict from available expression and ChIP-seq data which
combinations of Sox factors, together with appropriate partners,
are sufficient to generate desired cell states in culture fromplurip-26 Cell Stem Cell 12, January 3, 2013 ª2013 Elsevier Inc.otent or differentiated cells. Given that certain SOX genes are
amplified or overexpressed in human cancer, it is intriguing to
speculate that Sox factors also contribute to tumorigenesis by
endowing differentiated or progenitor cells with a more primitive
stemcell-like state. Indeed, studiesmanipulatingSox17 in hema-
topoiesis and Sox9 in mammary stem cells support this notion.
In summary, accumulating evidence implicates many Sox
factors in pluripotent and multipotent stem cell biology and
tissue regeneration. A better understanding of the mechanisms
by which Sox factors induce and maintain stem cell populations
should provide important insights into how tissue stem cells are
generated and maintained and might lead to strategies to treat
degenerative diseases or cancer affecting those tissues.
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